| P50 | author | Jillian G Baker | Q56480989 |
| P2860 | cites work | Cloning and functional expression of the human histamine H3 receptor | Q22009916 |
| | Histamine and its receptors | Q24670415 |
| | International Union of Pharmacology. XIII. Classification of histamine receptors | Q28249809 |
| | Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking | Q28609340 |
| | Some quantitative uses of drug antagonists | Q29616831 |
| | A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series | Q31126054 |
| | Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology | Q31976247 |
| | Partial agonists and G protein-coupled receptor desensitization | Q33677059 |
| | Inverse, protean, and ligand-selective agonism: matters of receptor conformation | Q33938998 |
| | Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists. | Q51795147 |
| | A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1-receptor. | Q51803397 |
| | (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. | Q54139679 |
| | The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor | Q34131536 |
| | Protean agonism at histamine H3 receptors in vitro and in vivo | Q34228615 |
| | Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor | Q34249836 |
| | Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist | Q34317159 |
| | Effects of histamine-trifluoromethyl-toluidide derivative (HTMT) on intracellular calcium in human lymphocytes | Q34339556 |
| | Isolation, characterization and antiplasmodial activity of steroidal alkaloids from Funtumia elastica (Preuss) Stapf | Q34415024 |
| | Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. | Q34536660 |
| | Constitutive activity of H3 autoreceptors modulates histamine synthesis in rat brain through the cAMP/PKA pathway. | Q34537179 |
| | Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist | Q34588721 |
| | Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine? | Q34650019 |
| | Highly potent and selective ligands for histamine H3-receptors | Q34661299 |
| | Comparison of some properties of pronethalol and propranolol | Q34794060 |
| | Receptors mediating some actions of histamine | Q34794929 |
| | The 'state' of beta-adrenoceptors | Q35045673 |
| | G-protein-coupled receptors: past, present and future. | Q35566599 |
| | Effect of histamine and histamine analogues on human isolated myometrial strips | Q35871304 |
| | Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 |
| | Molecular aspects of the histamine H3 receptor | Q36727499 |
| | Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. | Q36880896 |
| | A study of antagonist affinities for the human histamine H2 receptor | Q40141120 |
| | Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists | Q40613115 |
| | Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors. | Q40861070 |
| | beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists | Q41091060 |
| | Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors | Q41250262 |
| | Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation | Q42084998 |
| | Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling | Q42453523 |
| | Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex | Q42501463 |
| | Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium | Q43263994 |
| | Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists | Q43803802 |
| | Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor | Q44449928 |
| | Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses | Q44550635 |
| | Site of action of beta-ligands at the human beta1-adrenoceptor | Q45269915 |
| | Evidence for a secondary state of the human beta3-adrenoceptor. | Q46675954 |
| | Definition and antagonism of histamine H 2 -receptors | Q46704110 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | BMC Pharmacology | Q15767233 |
| P1476 | title | Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells | |
| P478 | volume | 8 | |